Recently, this journal published an interesting case report in which Hsieh et al [1] described an unusual presentation of a Cryptococcus infection in an elderly person. The diagnosis was made after a positive cerebrospinal fluid Cryptococcus antigen titer and a blood culture that grew Cryptococcus colonies. Unfortunately, there is frequently a lack of strain information, such as serotype or genotype, when an atypical Cryptococcus infection is described. However, from an epidemiologic point of view, it will be very informative and valuable to know which species of Cryptococcus caused the infection, for example, to further elucidate any possible link between the genetic background of clinical Cryptococcus strains and the patient category in which it is causing disease.
Currently, two pathogenic Cryptococcus species are known: Cryptococcus neoformans, which infects mainly immunocompromised individuals (e.g., HIV patients), and Cryptococcus gattii that seems to infect mainly apparently immunocompetent subjects [2] . Within the C. neoformans/C. gattii complex, seven genotypes can be distinguished using molecular techniques like M13 DNA fingerprinting, amplified fragment length polymorphism fingerprint analysis, and multilocus sequence typing of seven nuclear loci, which was recently launched by the ISHAM Cryptococcus genotyping Working Group [3, 4] .
Hereby, I would like to ask clinicians and health practitioners to consider one of the above-mentioned typing methods when they have diagnosed an unusual case of cryptococcosis. It will be valuable to the international cryptococcal research community when (clinical) strains are typed using one of these molecular approaches or, in the case that this is not possible, that the strain is deposited in one of the accessible (fungal) culture collections (e.g., CBS Fungal Biodiversity Centre, American Type Culture Collection) so that other researchers can further investigate these Cryptococcus strains in the future.
